USNA - USANA HEALTH SCI （）

USANA had a soft quarter due to China’s Covid surge. Read more to find out we see USNA stock as a buying opportunity with 65% upside.

DA Davidson has decided to maintain its Neutral rating of Usana Health Sciences (NYSE: USNA ) and lower its price target from $86.00 to $76.00. Shares of Usana Health Sciences are trading up 0.89% over the last 24 hours, at $76.19 per share. A move to $76.00 would account for a 0.25% decrease from the current share price. About Usana Health Sciences Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals'' … Full story available on Benzinga.com

USNA earnings call for the period ending March 31, 2022.

USANA Health Sciences, Inc. (NYSE:NYSE:USNA) Q1 2022 Results Conference Call April 27, 2022 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest -…

USANA Health Sciences Tops Q1 EPS by 1c

The USANA HEALTH SCIENCES, INC PAC successfully filed their F3XN QUATERLY YEAR-END with the coverage period of 07/01/2021 to 12/31/2021 and a confirmation ID of FEC-1564159 *********CommitteeId: C00709295 | FilingId: 1564159 | FormType: F3XN | CoverageFrom: 07/01/2021 | CoverageThrough: 12/31/2021 | ReportType: QUATERLY YEAR-END*********

USANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot sold 6,193 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, December 16th. The shares were sold at an average price of $102.25, for a total value of $633,234.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, []

Robeco Institutional Asset Management B.V. lowered its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 44.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,055 shares of the companys stock after selling 18,246 shares during the quarter. Robeco Institutional []

USANA Health Sciences, Inc. (NYSE:USNA) insider Daniel A. Macuga sold 368 shares of the firms stock in a transaction that occurred on Wednesday, December 8th. The shares were sold at an average price of $100.86, for a total transaction of $37,116.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which []

This is the 2nd hour in a row usna has seen its price head down. The post Usana Health Sciences Inc (USNA): Price Down $-0.92 (-0.91)% Over Past Day, Down $-0.58 (-0.57)% Over Past Hour appeared first on ETF Daily News .

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter results will be released after the close of market Tuesday, July 27, 2021. Shortly following the issuance of the Companys earnings release, the Company will post its Management Commentary document on the Companys website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional

The Latest survey report on Immune Health Product Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Immune Health Product organizations have the dual challenge of increasing interoperability to improve

Introducing USANA''s new Active Nutrition linesix science-based products for whole-body health SALT LAKE CITY, June 15, 2021 /CNW/ -- USANA Health Sciences, a global leader in nutrition, is proud to announce

Usana Health Sciences Inc (USNA) shares closed today at 1.6% below its 52 week high of $107.71, giving the company a market cap of $2B. The stock is currently up 38.1% year-to-date, up 23.6% over the past 12 months, and up 74.3% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 14.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Staples industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 215.0% The company's stock price performance over the past 12 months lags the peer average by -69.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 59.4% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Usana Health Sciences Inc (USNA) shares closed today at 1.2% below its 52 week high of $107.71, giving the company a market cap of $2B. The stock is currently up 38.1% year-to-date, up 23.6% over the past 12 months, and up 74.3% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 50.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Staples industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 212.9% The company's stock price performance over the past 12 months lags the peer average by -69.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 59.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.